Melinta Therapeutics, Llc drugs

7 results
  • baxdela - delafloxacin meglumine tablet

    (Delafloxacin Meglumine)
    Melinta Therapeutics, Llc
    Baxdela is a fluoroquinolone antibiotic for adults with acute bacterial skin and skin structure infections (ABSSSI) or community-acquired bacterial pneumonia (CABP) caused by susceptible bacteria.
  • kimyrsa - oritavancin diphosphate injection, powder, lyophilized, for solution

    (Oritavancin Diphosphate)
    Melinta Therapeutics, Llc
    KIMYRSA is a lipoglycopeptide antibiotic for treating acute bacterial skin and skin structure infections (ABSSSI) in adults caused by susceptible Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA), Streptococcus species, and vancomycin-susceptible Enterococcus faecalis.
  • orbactiv - oritavancin injection, powder, lyophilized, for solution

    (Oritavancin)
    Melinta Therapeutics, Llc
    ORBACTIV (oritavancin) treats acute bacterial skin and skin structure infections (ABSSSI) in adults caused by susceptible Gram-positive bacteria, including MRSA, Streptococcus species, and vancomycin-susceptible Enterococcus faecalis.
  • rezzayo - rezafungin injection, powder, lyophilized, for solution

    (Rezafungin)
    Melinta Therapeutics, Llc
    Rezzayo is an antifungal for adults 18+ with limited or no alternative options to treat candidemia and invasive candidiasis. Not studied for Candida-related endocarditis, osteomyelitis, or meningitis.
  • vabomere - meropenem - vaborbactam injection, powder, for solution

    (Meropenem-Vaborbactam)
    Melinta Therapeutics, Llc
    Vabomere (meropenem/vaborbactam) treats complicated urinary tract infections (cUTI), including pyelonephritis, in adults 18 and older caused by susceptible bacteria: Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae species complex.